CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Risk on as trade truce celebrations continue

Article By: ,  Senior Market Analyst
An upbeat start to December was more than evident in today’s session following the weekend’s trade war truce.  Investors were quick to put risk back on the table jumping into equities whilst flows out of safe havens were on the increase.   The FTSE jumped to a high of 7145 in early trade as oil & mining stocks traced commodity prices higher. This combined with a weaker pound and a stronger start on Wall Street ensured the FTSE was still up over 1.5% heading into the close.

Oil rebounds after heavy losses in November
Oil rallied over 5% on the trade truce and expected oil cuts. With the trade truce expected to keep demand expectations stable and the OPEC meeting set to reduce supply, this week looks set to be a win win for oil. The growing trade tensions between the worlds two biggest economies had weighed heavily on global trade and sparked fears of a global slowdown in growth, which hit sentiment for oil. Furthermore, oil was on the list of products facing import tariffs meaning its outlook had been bleak. After diving 20% in dismal November trading, the bulls are back, at least for now. Looking ahead to the OPEC meeting later this week, the market is starting to price in a substantial production cut as Russia affirmed continued cooperation with Saudi Arabia.

GSK dives on Tesaro deal
Despite the celebratory mood, investor goodwill failed to spread to GSK. GSK dived as investors reacted to GSK’s Tesaro deal. GSK agreed to buy Tesaro for $5.1 billion. This 60% premium to Tesaro’s closing price on Friday, proved too much for investors to stomach and sent GSK tumbling over 6%. GSK has previously sat on the side-lines as rivals engaged in deal making, a situation current Chief Executive Emma Walmsely is keen to change. However, her enthusiasm is clearly not share with shareholders. 

Sterling’s struggles continue
GBP/USD was ignoring dollar weakness and fell lower, as Brexit uncertainty overshadowed the risk on sentiment evident in every other corner of the market. The pound tumbled across the session, not even perked up by significantly better than forecast manufacturing activity data.

The manufacturing pmi jumped to 53.1 in November, up from 51.1 in October and significantly ahead of the 51.7 expected. However, delving deeper into the numbers, the jump is owing to an increase in domestic orders. This raises the question of how much of this is actually down to Brexit? With the probability of a no deal Brexit seemingly increasing by the day, stockpiling by firms could well be on the increase; a phenomenon that we expect to see more signs of as more firms initiate contingency plans.


StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024